Products for Research Use Only
RegisterLogin

NSD-IN-4

CAT: 0804-HY-168920Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-168920Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
NSD-IN-4 (Compound A8) is a potent and an orally active NSD3 inhibitor. NSD-IN-4 induces Apoptosis in a dose-dependent manner. NSD-IN-4 exhibits significant antitumor effects against lung squamous carcinoma[1].
UNSPSC
12352211
Target
Apoptosis; Histone Methyltransferase
Related Pathways
Apoptosis; Epigenetics
Field of Research
Cancer
Smiles
O=C(C(Cl)=C1NCCC2=CC=CC(F)=C2)C3=C(N=CC=C3)C1=O
Molecular Formula
C17H12ClFN2O2
Molecular Weight
330.74
References & Citations
[1]Xiu S, et al. Design, Synthesis, and Antitumor Activity of NSDs Inhibitors Targeting Lung Squamous Cell Carcinoma. European Journal of Medicinal Chemistry, 2025: 117388.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-162308-01NSD-IN-3
HY-134086-01NSD-IN-2
HY-155818NSD2-IN-4
HY-175871(Rac) -NSD2-PWWP1-IN-4
HY-W099255-01Ethyl 4,4,4,4',4',4'-hexafluoro-DL-valinate
HY-W7200064,4'-Diapo-ω, ω-carotene-4,4'-dial
HY-77910-014- (4-Bromophenyl) -4-hydroxypiperidine
HY-W0142264,4'-Dihydroxybenzophenone
HY-N90384',4''-Dihydroxyanigorootin
HY-W011927-014,4'-Sulfonyldiphenol

Alternative Products

CatalogName
T205139-01NSD-IN-4
BA4864-10NSD-IN-2
GTR19234869-01NSD-IN-3
T69101-01NSD-1034
CST 16144TNSD Family Antibody Sampler Kit
MBS604142-01NSD1 (NSD-1, Nuclear Receptor Binding SET Domain Protein 1, ARA267, ARA-267, Androgen Receptor-associated Coregulator 267, STO, SOTOS, Sotos Syndrome, FLJ22263)
PC64124,4,4-Trifluorobutyl 4,4,4-trifluorobutanoate
PC52154,4,4,4',4',4'-Hexafluorovaline hydrochloride
OR1011273-014,4',4'',4'''-Methanetetrayltetrabenzaldehyde
OR1011238-014,4,4,4-Silanetetrayltetrabenzaldehyde

Popular Products